Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.

Dilling, M B

Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. [electronic resource] - Cancer research Feb 1994 - 903-7 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

0008-5472


Carrier Proteins--physiology
Cell Division--drug effects
Child
Colonic Neoplasms--pathology
Heat-Shock Proteins--physiology
Humans
Immunosuppressive Agents--pharmacology
Polyenes--pharmacology
Receptor, IGF Type 1--physiology
Rhabdomyosarcoma--pathology
Sirolimus
Tacrolimus--pharmacology
Tacrolimus Binding Proteins
Tumor Cells, Cultured